Live feed16:05:00·57dPRReleasevia QuantisnowAbivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance Safety DatabaseByQuantisnow·Wall Street's wire, on your screen.ABVX· Abivax SAHealth Care
